Wegovy 1.7mg Flextouch Pre-Filled Pen + 4 Needles

Wegovy 1.7 mg FlexTouch Pre-Filled Pen is a prescription injectable medication containing semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist developed specifically for long-term chronic weight management in adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) with at least one weight-related health condition, such as high blood pressure, type 2 diabetes, or high cholesterol. The 1.7 mg dose is part of a structured dose escalation schedule that begins with lower introductory doses to help the body adjust and minimize early side effects. As patients progress, the higher weekly dose provides more significant appetite regulation and weight-loss support. Wegovy is administered once weekly by subcutaneous injection using the easy-to-use FlexTouch pre-filled pen. The four included needles allow safe, accurate self-injection into areas such as the abdomen, upper arm, or thigh. Before starting treatment, a healthcare provider will demonstrate proper injection technique and guide the dose escalation schedule. Regular clinical follow-up and monitoring help tailor therapy and ensure optimal outcomes as part of a comprehensive weight-management plan.